Advanced Glycation End Products, Measured as Skin Autofluorescence, at Diagnosis in Gestational Diabetes Mellitus Compared with Normal Pregnancy
| Autor: | Harold W. de Valk, Wendela L. de Ranitz-Greven, Dieuwke C. Bos, Douwe H. Biesma, Joline W. J. Beulens, Gerard H. A. Visser, Wendy K. Poucki |
|---|---|
| Přispěvatelé: | Epidemiology and Data Science, ACS - Diabetes & metabolism, ACS - Heart failure & arrhythmias, APH - Health Behaviors & Chronic Diseases |
| Rok vydání: | 2012 |
| Předmět: |
Adult
Blood Glucose Glycation End Products Advanced medicine.medical_specialty endocrine system diseases Endocrinology Diabetes and Metabolism Impaired glucose tolerance Endocrinology Predictive Value of Tests Pregnancy Surveys and Questionnaires Internal medicine Diabetes mellitus medicine Humans Mass Screening Prospective Studies Prospective cohort study Mass screening Netherlands Skin Glucose tolerance test medicine.diagnostic_test Obstetrics business.industry fungi nutritional and metabolic diseases Glucose Tolerance Test medicine.disease female genital diseases and pregnancy complications Gestational diabetes Diabetes Gestational Medical Laboratory Technology Spectrometry Fluorescence Hyperglycemia Gestation Female business |
| Zdroj: | De Ranitz-Greven, W L, Bos, D C, Poucki, W K, Visser, G H A, Beulens, J W J, Biesma, D H & De Valk, H W 2012, ' Advanced glycation end products, measured as skin autofluorescence, at diagnosis in gestational diabetes mellitus compared with normal pregnancy ', Diabetes Technology and Therapeutics, vol. 14, no. 1, pp. 43-49 . https://doi.org/10.1089/dia.2011.0105 Diabetes Technology and Therapeutics, 14(1), 43-49. Mary Ann Liebert Inc. |
| ISSN: | 1557-8593 1520-9156 |
| DOI: | 10.1089/dia.2011.0105 |
| Popis: | Background: Advanced glycation end products (AGEs) are tissue proteins that accumulate with age and in diabetes mellitus (DM). AGEs can be measured by the AGE-Reader (DiagnOptics Technologies BV, Groningen, The Netherlands), which measures skin autofluorescence (SAF). SAF has been suggested as a measure to screen for undiagnosed DM or impaired glucose tolerance. SAF has never been investigated in gestational DM (GDM). Therefore we compared SAF at diagnosis in GDM patients with normal pregnancy. If SAF is elevated in GDM, future research could focus on the possible use of the AGE-Reader as a screening method for GDM. Methods: In this monocenter observational study SAF was measured in 60GDM patients at diagnosis and 44 pregnant women without diabetes. Results: SAF did not differ between GDM at diagnosis (mean [SD], 1.74 [0.31] arbitrary units) and normal pregnancy (1.76 [0.32] arbitrary units). SAF was lower in white European patients than in patients with other ethnicity. Conclusions: This first study of tissue AGE accumulation in pregnancy shows no differences in SAF between women with GDM at diagnosis and normal pregnancy. This is most likely due to mild severity and short duration of hyperglycemia in GDM at diagnosis, but it does not exclude potential differences in SAF later in pregnancy. However, the fact that no differences are detected at diagnosis makes it unlikely that the AGE-Reader can be developed as a screening method for GDM in the future. Furthermore, we found that ethnicity should be taken into account when measuring SAF. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|